Cosmo Pharmaceuticals N.V. (COPN.SW) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Cosmo Pharmaceuticals N.V., with annual and quarterly history.
| Metric | 2025 |
|---|---|
| Valuation | |
| P/E Ratio | -491.19x |
| P/B Ratio | 3.74x |
| P/S Ratio | 17.21x |
| Profitability | |
| Gross Margin | 46.5% |
| Operating Margin | -10.0% |
| Net Margin | -3.5% |
| EBITDA Margin | 2.2% |
| Liquidity | |
| Current Ratio | 7.18x |
| Quick Ratio | 6.77x |
| Leverage | |
| Debt/Equity | 0.01x |
YoY = year-over-year change. Source: FMP..